Procyon Biopharma Inc. is pleased to announce that it has completed today the closing of the acquisition of Cellpep S.A. and the concurrent private placement of $18.1 million under the terms previously announced on January 19, 2006. Concurrently, Turenne Capital Partenaires (" Turenne "), the largest Cellpep shareholder, announces that, following the completion of these transactions, it now exercises control over more than 10% of the outstanding shares of Procyon.
